Position in BIIB
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$229,023
-$127,369 QoQ
Shares Held
1,060
-45.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#734
of 1,031 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PROATHLETE WEALTH MANAGEMENT LLC holds $1,603,662 across 13 Drug Manufacturers - General names. BIIB ranks #5 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,309 | $332,446 | |
| 2 | PFE |
Pfizer Inc
|
12,327 | $296,833 | |
| 3 | LLY |
ELI LILLY & Co
|
232 | $278,267 | |
| 4 | ABBV |
AbbVie Inc.
|
984 | $247,613 | |
| 5 | BIIB |
Biogen Inc.
This page
|
1,060 | $229,023 | |
| 6 | MRK |
Merck & Co., Inc.
|
956 | $122,845 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
930 | $53,586 | |
| 8 | NVS |
Novartis AG
|
162 | $25,388 |
All Filings in BIIB
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,023 | 1,060 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $356,392 | 1,944 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $370,986 | 2,108 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $289,684 | 2,068 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $259,833 | 2,069 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $282,835 | 2,067 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $281,984 | 1,844 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $357,440 | 1,844 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $427,476 | 1,844 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $412,500 | 1,913 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $497,873 | 1,924 | Shares | Sole | 2024-02-22 | |
| No filing history on record for this holder in this stock. | ||||||